Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
56
self-reported 51–200 band
Founded
2020
6 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Educational
self-reported
Description
The South Australian immunoGENomics Cancer Institute (SAiGENCI) is an independent cancer-focused medical research institute located in South Australia; focusing on cancer research and clinical trials, which will include new cutting-edge technologies in immunotherapies and genomics.
Official Adelaide University account.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUAHMS Building; cnr North Terrace and George Street; Adelaide, SA 5000Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at SAiGENCI?
The record holds 56 counted staff profiles at January 2026, inside the self-reported 51–200 band.
Where does SAiGENCI have offices?
One address on record, Australia only. Primary: AHMS Building, cnr North Terrace and George Street, Adelaide, SA 5000.
Has SAiGENCI raised funding?
None linked to this brand.
Which companies are listed alongside SAiGENCI?
Eight peer profiles on record: MiTSA and EMBL Australia.